These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7686186)

  • 1. Neutralizing antibodies in cats infected with feline immunodeficiency virus.
    Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Siebelink K; Osterhaus A; Bendinelli M
    J Clin Microbiol; 1993 Jun; 31(6):1626-9. PubMed ID: 7686186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus neutralizing antibody titer to feline immunodeficiency virus isolates of subtypes A, B and D in experimentally or naturally infected cats.
    Hohdatsu T; Fujimori S; Maeki M; Suma N; Motokawa K; Okada S; Koyama H
    J Vet Med Sci; 1997 May; 59(5):377-81. PubMed ID: 9192359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.
    Lombardi S; Garzelli C; Pistello M; Massi C; Matteucci D; Baldinotti F; Cammarota G; da Prato L; Bandecchi P; Tozzini F
    J Virol; 1994 Dec; 68(12):8374-9. PubMed ID: 7966629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.
    Del Mauro D; Matteucci D; Giannecchini S; Maggi F; Pistello M; Bendinelli M
    J Virol; 1998 Mar; 72(3):2199-207. PubMed ID: 9499077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FIV vaccine studies. I. Immune response to recombinant FIV env gene products and outcome after challenge infection.
    Lutz H; Hofmann-Lehmann R; Bauer-Pham K; Holznagel E; Tozzini F; Bendinelli M; Reubel G; Aubert A; Davis D; Cox D
    Vet Immunol Immunopathol; 1995 May; 46(1-2):103-13. PubMed ID: 7618250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dual-subtype vaccine against feline immunodeficiency virus infection.
    Hohdatsu T; Okada S; Motokawa K; Aizawa C; Yamamoto JK; Koyama H
    Vet Microbiol; 1997 Nov; 58(2-4):155-65. PubMed ID: 9453127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple in vitro methods for titrating feline immunodeficiency virus (FIV) and FIV neutralizing antibodies.
    Tozzini F; Matteucci D; Bandecchi P; Baldinotti F; Poli A; Pistello M; Siebelink KH; Ceccherini-Nelli L; Bendinelli M
    J Virol Methods; 1992 Jun; 37(3):241-52. PubMed ID: 1321834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross virus neutralizing antibodies against feline immunodeficiency virus genotypes A, B, C, D and E.
    Inoshima Y; Miyazawa T; Kohmoto M; Ikeda Y; Sato E; Hohdatsu T; Mathiason-Dubard C; Hoover EA; Mikami T
    Arch Virol; 1998; 143(1):157-62. PubMed ID: 9505973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
    Siebelink CH; Windrich RW; Chu I; Groen J; Weijer K; UytdeHaag FG; Osterhaus AD
    Dev Biol Stand; 1990; 72():189-96. PubMed ID: 2178115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of feline immunodeficiency virus vaccination, infection, or vaccination and infection in cats.
    Levy JK; Crawford PC; Kusuhara H; Motokawa K; Gemma T; Watanabe R; Arai S; Bienzle D; Hohdatsu T
    J Vet Intern Med; 2008; 22(2):330-4. PubMed ID: 18371028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
    Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
    AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization-induced decrease of the CD4+:CD8+ ratio in cats experimentally infected with feline immunodeficiency virus.
    Lehmann R; von Beust B; Niederer E; Condrau MA; Fierz W; Aubert A; Ackley CD; Cooper MD; Tompkins MB; Lutz H
    Vet Immunol Immunopathol; 1992 Dec; 35(1-2):199-214. PubMed ID: 1363009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feline immunodeficiency virus (FIV) infection in cats at necropsy: a serological study.
    Holznagel E; Lutz H; Steinhauer D; Reinacher M
    J Comp Pathol; 1997 May; 116(4):339-52. PubMed ID: 9179747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats.
    Dandekar S; Beebe AM; Barlough J; Phillips T; Elder J; Torten M; Pedersen N
    J Virol; 1992 Jul; 66(7):4040-9. PubMed ID: 1318395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative measurement of antibody inhibiting reverse transcriptase activity in cats naturally infected with feline immunodeficiency virus.
    Saito T; Suzuki K; Imai M; Inaba Y
    J Vet Med Sci; 1997 Sep; 59(9):841-3. PubMed ID: 9342714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
    Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
    Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive antibody protection of cats against feline immunodeficiency virus infection.
    Hohdatsu T; Pu R; Torres BA; Trujillo S; Gardner MB; Yamamoto JK
    J Virol; 1993 Apr; 67(4):2344-8. PubMed ID: 8383246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Densitometric analysis of Western blot assays for feline immunodeficiency virus antibodies.
    Calandrella M; Matteucci D; Mazzetti P; Poli A
    Vet Immunol Immunopathol; 2001 May; 79(3-4):261-71. PubMed ID: 11389960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of the viral antigen of feline immunodeficiency virus in the lymph nodes of cats at the early stage of infection.
    Toyosaki T; Miyazawa T; Furuya T; Tomonaga K; Shin YS; Okita M; Kawaguchi Y; Kai C; Mori S; Mikami T
    Arch Virol; 1993; 131(3-4):335-47. PubMed ID: 8102229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of feline immunodeficiency virus (FIV) proviral DNA in peripheral blood mononuclear cells of cats infected with Japanese strains of FIV.
    Inoshima Y; Tomonaga K; Ikeda Y; Miyazawa T; Mikami T
    J Vet Med Sci; 1995 Jun; 57(3):487-92. PubMed ID: 7548402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.